Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  hypoxia-activated prodrug TH-302
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients with Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed by Surgery
Status: Temporarily closed
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: N1153, NCI-2012-00095, CDR0000720022, NCCTG-N1153, NCT01497444
Hypoxia-Activated Prodrug TH-302 and Bevacizumab in Treating Patients with Glioblastoma Multiforme That Has Progressed after Previous Bevacizumab Therapy
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 12-0105, NCI-2013-00827, CTRC# 12-0105, HSC20130212H, NCT02342379
Start Over